Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 4 | 2024 | 285 | 1.370 |
Why?
|
| Caenorhabditis elegans | 4 | 2024 | 290 | 1.340 |
Why?
|
| Carrier Proteins | 2 | 2024 | 742 | 0.780 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 192 | 0.740 |
Why?
|
| Oocytes | 2 | 2022 | 172 | 0.680 |
Why?
|
| Gametogenesis | 1 | 2016 | 5 | 0.530 |
Why?
|
| Spermatozoa | 1 | 2016 | 91 | 0.500 |
Why?
|
| Homeostasis | 2 | 2024 | 605 | 0.300 |
Why?
|
| Organelles | 1 | 2024 | 54 | 0.210 |
Why?
|
| Lysosomes | 1 | 2024 | 137 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 149 | 0.200 |
Why?
|
| Meiosis | 1 | 2022 | 64 | 0.200 |
Why?
|
| Fertilization | 1 | 2022 | 42 | 0.200 |
Why?
|
| Mammals | 1 | 2022 | 272 | 0.170 |
Why?
|
| Aneuploidy | 2 | 2016 | 92 | 0.150 |
Why?
|
| Ethylamines | 1 | 2016 | 5 | 0.130 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 41 | 0.130 |
Why?
|
| Chelating Agents | 1 | 2016 | 68 | 0.130 |
Why?
|
| Animals | 4 | 2024 | 35307 | 0.130 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 166 | 0.130 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 228 | 0.120 |
Why?
|
| Cell Survival | 1 | 2016 | 1074 | 0.100 |
Why?
|
| Pyridines | 1 | 2016 | 478 | 0.100 |
Why?
|
| Genotype | 1 | 2016 | 1835 | 0.090 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2010 | 8 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 65 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2010 | 143 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 313 | 0.080 |
Why?
|
| Phenotype | 1 | 2016 | 3074 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6543 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 625 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1344 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2703 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1049 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 2342 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1204 | 0.030 |
Why?
|
| Male | 2 | 2016 | 63501 | 0.020 |
Why?
|
| Female | 2 | 2016 | 68543 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2010 | 15 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 57 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 645 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 947 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 851 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4926 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 1197 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2010 | 605 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1290 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1691 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 898 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 3233 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 7055 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 9745 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 10199 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 22032 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 31087 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 35495 | 0.000 |
Why?
|
| Humans | 1 | 2010 | 129248 | 0.000 |
Why?
|